175 related articles for article (PubMed ID: 1604003)
21. [Fractionated and hyperfractionated total body irradiation in the conditioning of allogenic bone marrow transplant in acute lymphatic leukemia. Results].
Corvò R; Frassoni F; Franzone P; Barra S; Guenzi M; Orsatti M; Fiorino R; Scarpati D; Vitale V
Radiol Med; 1989 Oct; 78(4):367-72. PubMed ID: 2687967
[TBL] [Abstract][Full Text] [Related]
22. T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect.
Barrett AJ; Mavroudis D; Tisdale J; Molldrem J; Clave E; Dunbar C; Cottler-Fox M; Phang S; Carter C; Okunnieff P; Young NS; Read EJ
Bone Marrow Transplant; 1998 Mar; 21(6):543-51. PubMed ID: 9543057
[TBL] [Abstract][Full Text] [Related]
23. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia.
Schots R; Van Riet I; Ben Othman T; Trullemans F; De Waele M; Van Camp B
Bone Marrow Transplant; 2001 Nov; 28(10):917-22. PubMed ID: 11753544
[TBL] [Abstract][Full Text] [Related]
24. Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients.
Kröger N; Zabelina T; Krüger W; Renges H; Stute N; Kabisch H; Jaburg N; Löliger C; Krüll A; Zander AR
Bone Marrow Transplant; 2001 Feb; 27(4):349-54. PubMed ID: 11313663
[TBL] [Abstract][Full Text] [Related]
25. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG
Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
[TBL] [Abstract][Full Text] [Related]
26. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
[TBL] [Abstract][Full Text] [Related]
27. Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA.
Mackinnon S; Barnett L; Bourhis JH; Black P; Heller G; O'Reilly RJ
Blood; 1992 Dec; 80(12):3235-41. PubMed ID: 1467526
[TBL] [Abstract][Full Text] [Related]
28. Interstitial pneumonitis after hyperfractionated total body irradiation in HLA-matched T-depleted bone marrow transplantation.
Latini P; Aristei C; Aversa F; Checcaglini F; Maranzano E; Panizza BM; Perrucci E; Carotti A; Martelli MF
Int J Radiat Oncol Biol Phys; 1992; 23(2):401-5. PubMed ID: 1587763
[TBL] [Abstract][Full Text] [Related]
29. Fractionated total body irradiation in allogeneic bone marrow transplantation in leukemia patients: analysis of prognostic factors and results in 136 patients.
Donato V; Iacari V; Zurlo A; Capua A; Tombolini V; Banelli E; Enrici RM; De Felice C; Giacco G; Iori AP; Arcese W; Biagini C
Radiother Oncol; 1998 Sep; 48(3):267-76. PubMed ID: 9925246
[TBL] [Abstract][Full Text] [Related]
30. Standard conditioning regimen and T-depleted donor bone marrow for transplantation in chronic myeloid leukemia.
Papa G; Arcese W; Mauro FR; Bianchi A; Alimena G; De Felice L; Isacchi G; Pasqualetti D; Malagnino F; Purpura M
Leuk Res; 1986; 10(12):1469-75. PubMed ID: 3540463
[TBL] [Abstract][Full Text] [Related]
31. T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphoma.
Przepiorka D; Giralt S; Huh YO; Andreeff M; Luna M; Reading C; Thomas M; Champlin RE
Transplant Proc; 1992 Dec; 24(6):2906-7. PubMed ID: 1465994
[No Abstract] [Full Text] [Related]
32. Immunohematological aspects of total body irradiation and bone marrow transplantation for the treatment of leukemia.
van Bekkum DW; Hagenbeek A
Radiother Oncol; 1990; 18 Suppl 1():30-6. PubMed ID: 2247647
[TBL] [Abstract][Full Text] [Related]
33. The Basel experience with total body irradiation for conditioning patients with acute leukemia for allogeneic bone marrow transplantation.
Speck B; Cornu P; Nissen C; Gratwohl A; Sartorius J
Pathol Biol (Paris); 1979 Jun; 27(6):353-5. PubMed ID: 388310
[TBL] [Abstract][Full Text] [Related]
34. Prevention of graft-versus-host disease by ex vivo T cell depletion: reduction in graft failure with augmented total body irradiation.
Burnett AK; Hann IM; Robertson AG; Alcorn M; Gibson B; McVicar I; Niven L; Mackinnon S; Hambley H; Morrison A
Leukemia; 1988 May; 2(5):300-3. PubMed ID: 3287016
[TBL] [Abstract][Full Text] [Related]
35. Preclinical analysis of treosulfan in combination with total body irradiation as conditioning regimen prior to bone marrow transplantation in rats.
Sender V; Hofmeister-Mielke N; Sievert K; Teifke JP; Vogel H; Baumgart J; Pichlmeier U; Freund M; Casper J; Wolff D
Immunopharmacol Immunotoxicol; 2009; 31(4):595-600. PubMed ID: 19874228
[TBL] [Abstract][Full Text] [Related]
36. Lung damage following bone marrow transplantation after hyperfractionated total body irradiation.
Latini P; Aristei C; Aversa F; Checcaglini F; Maranzano E; Raymondi C; Panizza BM; Perrucci E; Martelli MF
Radiother Oncol; 1991 Oct; 22(2):127-32. PubMed ID: 1957002
[TBL] [Abstract][Full Text] [Related]
37. Hyperfractionated total body irradiation for T-depleted HLA identical bone marrow transplants.
Latini P; Checcaglini F; Maranzano E; Aristei C; Panizza BM; Gobbi G; Raymondi C; Aversa F; Martelli MF
Radiother Oncol; 1988 Feb; 11(2):113-8. PubMed ID: 3281187
[TBL] [Abstract][Full Text] [Related]
38. Effect of total body irradiation dose escalation on outcome following T-cell-depleted allogeneic bone marrow transplantation.
Alyea E; Neuberg D; Mauch P; Marcus K; Freedman A; Webb I; Anderson K; Schlossman R; Fisher D; Gribben J; Ritz J; Soiffer R
Biol Blood Marrow Transplant; 2002; 8(3):139-44. PubMed ID: 11939603
[TBL] [Abstract][Full Text] [Related]
39. Influence of fractionated total body irradiation on mucosal toxicity in intensified conditioning regimens for autologous bone marrow transplantation in pediatric cancer patients.
Borgmann A; Emminger W; Emminger-Schmidmeier W; Peters C; Gatterer-Menz I; Henze G; Gadner H
Klin Padiatr; 1994; 206(4):299-302. PubMed ID: 7967427
[TBL] [Abstract][Full Text] [Related]
40. T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease.
Papadopoulos EB; Carabasi MH; Castro-Malaspina H; Childs BH; Mackinnon S; Boulad F; Gillio AP; Kernan NA; Small TN; Szabolcs P; Taylor J; Yahalom J; Collins NH; Bleau SA; Black PM; Heller G; O'Reilly RJ; Young JW
Blood; 1998 Feb; 91(3):1083-90. PubMed ID: 9446672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
